News FAMHP

There are 2 result(s) found based on your search criteria

1-2 from 2 result(s)

Coronavirus: European Medicines Agency recommends continued use of medicinal products for high blood pressure, heart and kidney disease

European Medicines Agency (EMA) is aware of reports that certain medicinal products, commonly used to treat high blood pressure, heart failure or kidney disease, may aggravate the coronavirus infection (COVID-19). EMA does not recommend stopping these treatments.

Coronavirus: COVID-19 patients should also report adverse reactions

The European Medicines Agency (EMA) and the Federal Agency for Medicines and Health Products (FAMHP) would like to remind patients, particularly those with or suspected of having COVID-19, that they can report adverse effects believed to be associated with taking one or more medicinal products.

1-2 from 2 result(s)